King of Prussia, PA, United States of America

Tritin Tran

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 13.3

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2010-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tritin Tran: Innovator in Pharmacological Imaging

Introduction

Tritin Tran, an inventive mind based in King of Prussia, PA, has made notable contributions to the field of pharmacology through his innovative patents. With a focus on imaging technologies, Tran has garnered attention for his work aimed at improving the quantitative imaging of specific receptors in mammals.

Latest Patents

Tran holds two patents, with his most recent focusing on "Radioligands for Imaging the LPA-1 Receptor." This invention relates to radiolabeled LPA1 receptor antagonists and pharmaceutically acceptable salts that are instrumental in imaging LPA1 receptors in mammals. The compounds developed in this patented technology are formulated to enhance the accuracy and effectiveness of imaging biological processes.

Career Highlights

Throughout his career, Tritin Tran has worked with esteemed organizations in the pharmaceutical industry, including Wyeth and Bristol-Myers Squibb Company. His professional journey reflects a commitment to advancing medical imaging techniques and contributing valuable insights within the research community.

Collaborations

Tran has collaborated with notable colleagues in his field, including Hwei-Ru Tsou and Semiramis Ayral-Kaloustian. These partnerships have been pivotal in developing his innovations and enhancing the research outcomes of their projects.

Conclusion

Tritin Tran’s contributions to pharmacological imaging set a foundation for future advancements in medical technology. His patents not only showcase his inventiveness but also demonstrate the importance of collaboration and innovation in achieving breakthroughs in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…